Funding sources R.B. is in receipt of support by an educational grant from the Ministry of Higher Education in Saudi Arabia. A.B. received a personal award from the NIHR (U.K.).
CLINICAL AND LABORATORY INVESTIGATIONS
Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates
Article first published online: 29 OCT 2012
© 2012 The Authors. BJD © 2012 British Association of Dermatologists
British Journal of Dermatology
Volume 167, Issue 5, pages 1053–1066, November 2012
How to Cite
Bagabir, R., Byers, R.J., Chaudhry, I.H., Müller, W., Paus, R. and Bayat, A. (2012), Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates. British Journal of Dermatology, 167: 1053–1066. doi: 10.1111/j.1365-2133.2012.11190.x
Conflicts of interest None declared.
- Issue published online: 29 OCT 2012
- Article first published online: 29 OCT 2012
- Accepted for publication 17 June 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.